OTHER TRANSACTION FOR ADVANCED RESEARCH (OTAR) BETWEENOther Transaction Authority Agreement • November 3rd, 2023 • Vir Biotechnology, Inc. • Biological products, (no disgnostic substances)
This Agreement is entered into between the Department of Health and Human Services (HHS) Biomedical Advanced Research & Development Authority (BARDA) and Vir Biotechnology, Inc. (Vir) pursuant to and under U.S. Federal law.
Agreement No.: 75A50122C00081Vir Biotechnology, Inc. • November 3rd, 2023 • Biological products, (no disgnostic substances)
CUN PRISMline item Title Requisition (OS) Appropriation Year CAN Object Class Amt. (Govt Share) Changed or Unchanged 0001 0001 Base Period: VIR-2482- 4002 PENNISULA Phase 2 study [***] 2022 [***] 25103 $50,000,000.00 Unchanged 0001 0001 Base Period: VIR-2482- 4002 PENNISULA Phase 2 study [***] 2022 [***] 25103 $5,000,000.00 Unchanged 0001 0001 VIR-2482-4002 PENNISULA Phase 2 study [***] 2023 [***] 25106 +$11,249,523.00 Changed 0013 0002 Option 12- FASTx VIR- 7229 [***] 2023 [***] 25106 +$40,000,000.00 Changed 0014 0003 Option 12- FASTx [***] [***] 2023 [***] 25106 +$2,976,862.50 Changed 0014 0004 Option 12- FASTx [***] [***] 2023 [***] 25106 +$7,074,015.50 Changed Total $55,000,000.00+61,300,401.00 Changed $116,300,401.00
Separation Agreement by and betweenSeparation Agreement • November 3rd, 2023 • Vir Biotechnology, Inc. • Biological products, (no disgnostic substances)
